↓ Skip to main content

Dove Medical Press

Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin

Overview of attention for article published in Lung Cancer: Targets and Therapy, March 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#14 of 128)
  • Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter
8 X users
patent
1 patent

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
28 Mendeley
Title
Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin
Published in
Lung Cancer: Targets and Therapy, March 2020
DOI 10.2147/lctt.s239223
Pubmed ID
Authors

Diego Kauffmann-Guerrero, Rudolf Maria Huber

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 18%
Student > Postgraduate 4 14%
Student > Ph. D. Student 3 11%
Researcher 3 11%
Student > Master 2 7%
Other 1 4%
Unknown 10 36%
Readers by discipline Count As %
Medicine and Dentistry 7 25%
Biochemistry, Genetics and Molecular Biology 5 18%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Immunology and Microbiology 1 4%
Agricultural and Biological Sciences 1 4%
Other 2 7%
Unknown 10 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2021.
All research outputs
#3,704,753
of 25,387,668 outputs
Outputs from Lung Cancer: Targets and Therapy
#14
of 128 outputs
Outputs of similar age
#80,657
of 383,477 outputs
Outputs of similar age from Lung Cancer: Targets and Therapy
#1
of 3 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 128 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 383,477 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them